Successful transition from Treprostinil to Selexipag in patient with severe pulmonary arterial hypertension

In this report, we describe the first successful case of transition from subcutaneous administration of treprostinil to selexipag in a patient with severe pulmonary arterial hypertension (PAH), by evaluating hemodynamic changes and exercise tolerance.